{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:04:55Z","timestamp":1784066695729,"version":"3.55.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,14]]},"DOI":"10.7759\/cureus.112669","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:39:37Z","timestamp":1784065177000},"source":"Crossref","is-referenced-by-count":0,"title":["A 76-Year-Old Man With Hemorrhagic Stroke, Recurrent Thromboembolic Events, and Atrial Fibrillation Under Optimal Medical Treatment: When Anticoagulants Fail"],"prefix":"10.7759","author":[{"given":"Stavroula A","family":"Siopi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimokritos","family":"Dimitriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.005119","article-title":"Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study","volume":"129","author":"Chugh SS","year":"2014","unstructured":"Chugh SS, Havmoeller R, Narayanan K, et al.. Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation. 2014, 129:837-47. 10.1161\/CIRCULATIONAHA.113.005119","journal-title":"Circulation"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder IC","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, et al.. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024, 45:3314-414. 10.1093\/eurheartj\/ehae176","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik P","year":"2020","unstructured":"Osmancik P, Herman D, Neuzil P, et al.. Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2020, 75:3122-35. 10.1016\/j.jacc.2020.04.067","journal-title":"J Am Coll Cardiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00298-2","article-title":"Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial","volume":"20","author":"Schreuder F","year":"2021","unstructured":"Schreuder F, van Nieuwenhuizen KM, Hofmeijer J, et al.. Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial. Lancet Neurol. 2021, 20:907-16. 10.1016\/S1474-4422(21)00298-2","journal-title":"Lancet Neurol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.04.131","article-title":"Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: observations from the SPORTIF trials","volume":"216","author":"Proietti M","year":"2016","unstructured":"Proietti M, Lane DA, Lip GY. Relation of the SAMe-TT2R2 score to quality of anticoagulation control and thromboembolic events in atrial fibrillation patients: observations from the SPORTIF trials. Int J Cardiol. 2016, 216:168-72. 10.1016\/j.ijcard.2016.04.131","journal-title":"Int J Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock RP","year":"2021","unstructured":"Whitlock RP, Belley-Cote EP, Paparella D, et al.. Left atrial appendage occlusion during cardiac surgery to prevent stroke. N Engl J Med. 2021, 384:2081-91. 10.1056\/NEJMoa2101897","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/icvts\/ivab334","article-title":"Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation","volume":"34","author":"Cartledge R","year":"2022","unstructured":"Cartledge R, Suwalski G, Witkowska A, et al.. Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation. Interact Cardiovasc Thorac Surg. 2022, 34:548-55. 10.1093\/icvts\/ivab334","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy VY","year":"2017","unstructured":"Reddy VY, Doshi SK, Kar S, et al.. 5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials. J Am Coll Cardiol. 2017, 70:2964-75. 10.1016\/j.jacc.2017.10.021","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2015.08.035","article-title":"Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience","volume":"8","author":"Price MJ","year":"2015","unstructured":"Price MJ, Reddy VY, Valderr\u00e1bano M, et al.. Bleeding outcomes after left atrial appendage closure compared with long-term warfarin: a pooled, patient-level analysis of the WATCHMAN randomized trial experience. JACC Cardiovasc Interv. 2015, 8:1925-32. 10.1016\/j.jcin.2015.08.035","journal-title":"JACC Cardiovasc Interv"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy VY","year":"2013","unstructured":"Reddy VY, Doshi SK, Sievert H, et al.. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial. Circulation. 2013, 127:720-9. 10.1161\/CIRCULATIONAHA.112.114389","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccep.2019.11.007","article-title":"Periprocedural imaging for left atrial appendage closure: computed tomography, transesophageal echocardiography, and intracardiac echocardiography","volume":"12","author":"Gilhofer TS","year":"2020","unstructured":"Gilhofer TS, Saw J. Periprocedural imaging for left atrial appendage closure: computed tomography, transesophageal echocardiography, and intracardiac echocardiography. Card Electrophysiol Clin. 2020, 12:55-65. 10.1016\/j.ccep.2019.11.007","journal-title":"Card Electrophysiol Clin"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2020.11.029","article-title":"Association of hospital procedural volume with outcomes of percutaneous left atrial appendage occlusion","volume":"14","author":"Nazir S","year":"2021","unstructured":"Nazir S, Ahuja KR, Kolte D, et al.. Association of hospital procedural volume with outcomes of percutaneous left atrial appendage occlusion. JACC Cardiovasc Interv. 2021, 14:554-61. 10.1016\/j.jcin.2020.11.029","journal-title":"JACC Cardiovasc Interv"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.26903","article-title":"Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet","volume":"90","author":"Lempereur M","year":"2017","unstructured":"Lempereur M, Aminian A, Freixa X, et al.. Device-associated thrombus formation after left atrial appendage occlusion: a systematic review of events reported with the Watchman, the Amplatzer Cardiac Plug and the Amulet. Catheter Cardiovasc Interv. 2017, 90:111-21. 10.1002\/ccd.26903","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2022.03.001","article-title":"Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry","volume":"8","author":"Alkhouli M","year":"2022","unstructured":"Alkhouli M, Du C, Killu A, et al.. Clinical impact of residual leaks following left atrial appendage occlusion: insights from the NCDR LAAO registry. JACC Clin Electrophysiol. 2022, 8:766-78. 10.1016\/j.jacep.2022.03.001","journal-title":"JACC Clin Electrophysiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/498484-a-76-year-old-man-with-hemorrhagic-stroke-recurrent-thromboembolic-events-and-atrial-fibrillation-under-optimal-medical-treatment-when-anticoagulants-fail","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T21:39:37Z","timestamp":1784065177000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/498484-a-76-year-old-man-with-hemorrhagic-stroke-recurrent-thromboembolic-events-and-atrial-fibrillation-under-optimal-medical-treatment-when-anticoagulants-fail"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,14]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.112669","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,14]]}}}